Therapeutic Radioisotopes Market

Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic Radioisotopes Market contains market size and forecasts of Therapeutic Radioisotopes in global, including the following market information:
Global Therapeutic Radioisotopes Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Therapeutic Radioisotopes Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Therapeutic Radioisotopes companies in 2021 (%)
The global Therapeutic Radioisotopes market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radium-223 Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Therapeutic Radioisotopes include Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Lantheus and Spectrum Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Therapeutic Radioisotopes manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:

• Radium-223
• Lutetium-177
• Iodine-131
• Other

• Thyroid
• Bone Metastasis
• Lymphoma
• Other

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

• Key companies Therapeutic Radioisotopes revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Therapeutic Radioisotopes revenues share in global market, 2021 (%)
• Key companies Therapeutic Radioisotopes sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Therapeutic Radioisotopes sales share in global market, 2021 (%)

• Bayer
• Novartis
• China Isotope & Radiation
• Dongcheng
• Q BioMed
• Curium Pharmaceuticals
• Jubilant DraxImage
• Lantheus
• Spectrum Pharmaceuticals
• Progenics Pharmaceuticals
• International Isotopes